Latest / Investor Exchange / How Top Glove Staged A Remarkable Recovery In FY2025

Transcript

How Top Glove Staged A Remarkable Recovery In FY2025 · Investor Exchange

• 0:02
  Time for another Investor Exchange podcast. Here are your hosts, Matt and Sally.
• 0:07
  Okay, let's unpack this. We're diving into a, well, quite a dramatic financial story today.
• 0:13
  Really shows the ups and downs in the global healthcare supply chain.
• 0:16
  We're focusing specifically on Top Club Corporation BHD, that's TGCB,
• 0:21
  and their latest results for the financial year ending August 34, 2025.
• 0:27
  FY 2025. Yeah, it's a fascinating one. Our mission really is to get past the
• 0:32
  headlines because you see this huge swing.
• 0:34
  A company that, frankly, was struggling with some pretty big losses has suddenly
• 0:38
  posted significant profits.
• 0:40
  Right. We need to figure out what actually drove that. And crucially, is it sustainable?
• 0:44
  It's still a really tough market out there. It is. And for you,
• 0:47
  the learner, this is fundamentally a story about recovery, a quite remarkable
• 0:51
  recovery, navigating that post-pandemic market correction.
• 0:54
  When you look at the FY 2025 numbers, it's not just small steps.
• 0:58
  It's a, well, it's a full-scale turnaround, both operationally and financially.
• 1:02
  Okay, let's get into the hard numbers then.
• 1:04
  Comparing FY 2025 to FY 2024, I mean, the difference is pretty stark, isn't it? It really is.
• 1:10
  Full-year revenue jumped 39% year-in-year. So that's RM3.5 billion.
• 1:14
  But the number that really jumped out at me was sales volume.
• 1:17
  The actual number of gloves shipped. That soared 55% year on year.
• 1:21
  That's just a massive amount of product moving. And that volume increase,
• 1:25
  that's the absolute foundation for the profit turnaround we saw.
• 1:28
  Because the real story, the kind of aha moment, is in the profitability metrics.
• 1:33
  Remember, FY 2024, they had that loss before tax PBT of RM31 million,
• 1:39
  a loss. Yeah, I remember that.
• 1:40
  Now, fast forward to FY 2025, that PBT didn't just recover. it's strengthened
• 1:45
  massively to RM 154 million.
• 1:49
  Wow. That's what, nearly a 600% swing from loss to profit?
• 1:53
  Okay, so that kind of swing suggests the efficiency efforts really paid off.
• 1:56
  But sometimes, you know, huge volume growth can just mean they're chasing revenue,
• 2:00
  maybe cutting prices too much.
• 2:02
  Did the net profit look healthy too? It did, actually. That's the encouraging
• 2:05
  part. The financial discipline seems evident.
• 2:07
  Profit attributable to owners Patamai that swung from a loss of RM 65 million
• 2:12
  in FY 24 to a profit of RM 109 million in FY 24. Okay. So bottom line, positive two.
• 2:18
  Exactly. Which means the basic earnings per share, the EPS, went from negative
• 2:23
  0.81 cent to positive 1.36 cents. Like the whole profitability structure got reset.
• 2:29
  So they were like climbing out of the valley, financially speaking.
• 2:32
  That's a good way to put it.
• 2:33
  All right. So if that 55% volume growth was the engine...
• 2:37
  What was the fuel? The initial report just said stronger glove demand. That feels a bit vague.
• 2:42
  What really caused that demand to pick up so much momentum through FY 2025?
• 2:47
  Any deeper insights there? Yeah, what's fascinating here is understanding the inventory cycle.
• 2:53
  You have to remember during the peak pandemic times, everyone,
• 2:56
  distributors, hospitals, they built up massive stockpiles, safety stocks. Right, overordering.
• 3:01
  Exactly. So FY 2024 was largely about using up that excess inventory, burning it off.
• 3:06
  By FY 2025, particularly as the year went on, those stockpiles were finally depleted.
• 3:11
  So the demand wasn't panic buying anymore. It was more like stable, necessary restocking.
• 3:15
  Plus the baseline demand that's always there from health care,
• 3:18
  industrial, food and coverage sectors.
• 3:20
  So the market just started buying normally again, basically.
• 3:23
  And Top Club's main operational lever to meet that was boosting utilization.
• 3:28
  Precisely. Utilization is like the magic number in this kind of capital-intensive
• 3:33
  manufacturing, by August 2025, they'd pushed their utilization rate up substantially
• 3:38
  to about 75% of their running capacity.
• 3:42
  Okay, 75%. Sounds pretty good after the lows. It's critical because moving from,
• 3:47
  say, 50% utilization towards 75% creates huge operating leverage. Meaning?
• 3:53
  Explain that a bit. Meaning all those big fixed costs, the factories,
• 3:57
  the machines, the core staff, They get spread out over a much,
• 4:01
  much larger volume of gloves, 55% more gloves in this case.
• 4:05
  Right. So the cost to make each individual glove goes down.
• 4:07
  Significantly cheaper per unit. And that enabled them to manage costs better,
• 4:11
  offer more competitive pricing. And still make better margins.
• 4:14
  Exactly. It becomes a kind of virtuous cycle of efficiency. That makes sense.
• 4:17
  Demand recovers, they ramp up utilization, that drives efficiency,
• 4:21
  which lets them price competitively to capture even more of that recovering demand.
• 4:26
  What about raw materials? Were prices helping them out too?
• 4:29
  They were, yes. That was definitely an external tailwind.
• 4:33
  Favorable raw material prices helped cushion some other cost pressures. Like what?
• 4:37
  Well, for instance, mitigating the impact of a weaker U.S. dollar relative to their local currency.
• 4:42
  Remember, they export a lot. Oh, right. The currency effect.
• 4:45
  So you had the synergy, good internal cost control meeting, helpful external price conditions.
• 4:51
  Okay, the full year picture is impressive. A real turnaround.
• 4:53
  But, you know, annual numbers can sometimes hide slowing momentum towards the
• 4:57
  end. Here's where it gets really interesting, I think. Let's zoom into the quarterly performance.
• 5:01
  Q4 FY 2025.
• 5:04
  Is the success accelerating or starting to plateau? Good question.
• 5:07
  Looking at Q4 specifically gives us a better feel for the current trajectory.
• 5:11
  So year on year, Q4 FY25 versus Q4 FY24, the profit before tax,
• 5:17
  PBT, expanded by a massive 700 percent, up to RM48 million for the quarter. 700 percent.
• 5:23
  OK, so momentum definitely held up compared to the previous year's Q4.
• 5:27
  But even quarter-on-quarter, comparing Q4 FY25 against the immediately preceding quarter, Q3 FY25,
• 5:34
  revenue was up another 7%, and profit from operations surged 313% just in that single quarter.
• 5:42
  313% quarter-on-quarter profit growth? How? Well, the key driver, again, was volume.
• 5:48
  Sales volume jumped 18% just in that last quarter alone.
• 5:52
  Wow. So that 75% utilization wasn't a peak.
• 5:55
  It was still building. It seems like it was deepening, yeah.
• 5:57
  They were getting more efficient even as they produced more.
• 6:00
  And crucially, those helpful raw material prices, they continued into the end of the year.
• 6:05
  Natural latex concentrate prices dropped 14% quarter-on-quarter in Q4.
• 6:09
  Nitrile latex prices were down 10%.
• 6:12
  So volume's going up sharply while key input costs are falling sharply.
• 6:15
  Dingo! That's how you get a 313% surge in operating profit in one quarter.
• 6:20
  Okay, that operational success must have thrown off a lot of cash then.
• 6:23
  It certainly did. Net cash generated from operating activities.
• 6:26
  It improved dramatically.
• 6:27
  For the full year, FY 2025, it hit RM300 million compared to what the year before.
• 6:33
  Compared to just RM20.7 million in FY 2024.
• 6:37
  That's a huge difference. A night and day difference. And it's that strong operational
• 6:41
  cash flow that really enabled, I think, the most significant financial move
• 6:45
  they made during the year.
• 6:46
  Right. Let's talk about that. The debt restructuring.
• 6:48
  It sounds a bit complex, but strategically important, right?
• 6:51
  Very important, because it answers the question.
• 6:53
  What do you do with RM300 million in fresh operating cash?
• 6:58
  TGCB used it in part for a major balance sheet cleanup.
• 7:01
  In February 2025, they redeemed and canceled a very large RM1.18 billion perpetual sukuk.
• 7:09
  Okay, hang on. For listeners, maybe quickly explain what a perpetual sukuk is
• 7:14
  and why getting rid of it is a big deal. Sure.
• 7:16
  So a perpetual sukuk is a bit like hybrid debt equity.
• 7:19
  It doesn't have a fixed maturity date. The company theoretically never has to
• 7:23
  repay the principal amount. Okay.
• 7:25
  Sounds good. Well, yes and no. It often comes with higher distribution costs
• 7:28
  like dividends, and it can complicate the balance sheet. Is it debt?
• 7:32
  Is it equity? It can be complex.
• 7:34
  So removing an obligation, that large RM 1.18 billion, brings a lot of financial clarity.
• 7:41
  It removes a pretty substantial ongoing payout obligation that had this kind
• 7:45
  of complex equity-like structure. Got it.
• 7:48
  Simplifies things. Right. And they funded part of that redemption,
• 7:51
  getting rid of the RM 1.18 billion by issuing a new smaller debt instrument,
• 7:56
  an RM 800 million senior Sukuk Wakala.
• 7:59
  So they swapped a bigger, complex obligation for a smaller, more standard one. Exactly.
• 8:04
  They traded the large perpetual instrument for a smaller senior fixed income bond, basically.
• 8:09
  This new one has a known fixed distribution rate of 4.22 percent per year.
• 8:13
  I see. So the net effect is lower long-term liability, a simpler capital structure,
• 8:18
  and it frees up future cash flow that would have gone to servicing that larger,
• 8:22
  more complex perpetual debt.
• 8:23
  That strong operational cash flow made this whole swap possible.
• 8:27
  Okay, so that improved operational base and the cleaner balance sheet must give
• 8:32
  them more confidence looking ahead. Let's shift to the outlook.
• 8:35
  The first signal they sent about this renewed confidence, I guess,
• 8:38
  was bringing back dividends. That's right. A clear signal.
• 8:42
  After getting back to profitability, they declared a final dividend, 0.48 sen per share.
• 8:48
  Which isn't huge per share, but the act itself is significant.
• 8:52
  It is. Declaring a dividend is often seen as management signaling they believe
• 8:56
  the profitability is sustainable, you know, not just a one-off lucky year. Makes sense.
• 9:01
  But what about the market itself? They had a great recovery, yes.
• 9:05
  But the competition hasn't exactly vanished, has it? No, definitely not.
• 9:09
  And if we connect this to the bigger picture, their forward strategy seems very
• 9:13
  focused, almost defensive in a way.
• 9:15
  They say they're optimistic long-term about Glove's essential product,
• 9:18
  right? Yeah. Healthcare, industrial, F&B.
• 9:21
  But they are also very aware of the intense competition, especially from other
• 9:25
  lower-cost manufacturers, many in the Aegean region.
• 9:27
  So how are they planning to deal with that, that pressure from regional competitors?
• 9:32
  Their big strategic pivot seems to be a clear focus on significantly growing
• 9:36
  their U.S. market share by FY2026. Why the U.S.
• 9:40
  Specifically? Well, the U.S. market often demands higher regulatory hurdles,
• 9:44
  which can be a barrier to entry for some.
• 9:47
  It also tends to allow for more premium pricing on specialized gloves.
• 9:50
  Ah, higher margins potentially. Higher margins and often more stable long-term
• 9:55
  contracts. So it's seen as a more defensible market compared to,
• 9:58
  say, regions where it's purely a volume and price game against aggressive competitors.
• 10:04
  OK, focus on the U.S. But even so, they still talked about challenges,
• 10:07
  didn't they? They mentioned a VUCA environment.
• 10:10
  What specific Edwin's are still out there? Yeah.
• 10:13
  VUCA, volatile, uncertain, complex, ambiguous.
• 10:17
  Beyond just the heightened competition, they specifically called out things
• 10:20
  like ongoing labor shortages.
• 10:22
  It's all an issue. Apparently so. And the generally rising costs of doing business
• 10:25
  utilities, wages, compliance costs, all that. So how do they fight that?
• 10:29
  Their plan seems to rely heavily on maintaining really strict quality control,
• 10:34
  which helps justify premium pricing and continuous cost optimization,
• 10:39
  trying to squeeze every bit of efficiency out of that 75 percent utilization.
• 10:44
  Makes sense. And it's worth mentioning the innovation angle,
• 10:47
  too. They're not just making standard gloves. They highlighted new products.
• 10:50
  Like what? Things like extensively tested chemotherapy nitrile gloves,
• 10:55
  very specialized and biodegradable diamonds sandblast nitrile gloves,
• 11:00
  niche high value stuff. Right.
• 11:02
  Trying to differentiate beyond just bulk volume, sustainability and safety angles.
• 11:06
  Exactly. It helps position them away from purely low cost producers.
• 11:10
  OK, so let's try and summarize this deep dive.
• 11:12
  FY 2025 for Topglove was really defined by accelerating growth,
• 11:17
  driven by that huge jump in volume and much better efficiency.
• 11:20
  And this was enabled, partly at least, by the market finally working through
• 11:24
  those old stockpiles. The timing was good for them.
• 11:26
  And that success let them pull off that big balance sheet cleanup,
• 11:30
  swapping out the perpetual sukuk and setting a clearer strategic path towards the U.S.
• 11:34
  Market. Yeah, they delivered genuinely healthy results. It wasn't just smoke and mirrors.
• 11:39
  The tough operational discipline they likely needed during the loss-making period
• 11:44
  seems to have really paid off now.
• 11:46
  So the focus shifts now, maybe from just survival back towards strategic expansion. I think that's right.
• 11:51
  And that actually leads nicely into a final thought for you,
• 11:54
  the listener, to maybe ponder. Consider this.
• 11:57
  They swapped that big RM 1.18 billion perpetual sukuk for a smaller fixed rate
• 12:04
  RM 800 million senior sukuk.
• 12:06
  At the same time, they're now generating strong operating cash flow,
• 12:10
  that RM 300 million figure. So they have significantly improved financial flexibility now, right?
• 12:16
  Less complex debt, lower overall burden, and strong cash coming in.
• 12:20
  How might this stronger financial position, this reduced cost of capital,
• 12:24
  allow them to be perhaps more aggressive or maybe more resilient in chasing that U.S. market share?
• 12:28
  Especially thinking about the capital-needed inventory, maybe specialized production
• 12:31
  lines, particularly if U.S.
• 12:33
  Market demand shifts quickly or becomes more competitive itself.
• 12:36
  How does this financial restructuring better equip them for that specific strategic battle ahead?